Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

38 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Predictive value of tumour cell proliferation in locally advanced breast cancer treated with neoadjuvant chemotherapy.
Aas T, Geisler S, Eide GE, Haugen DF, Varhaug JE, Bassøe AM, Thorsen T, Berntsen H, Børresen-Dale AL, Akslen LA, Lønning PE. Aas T, et al. Eur J Cancer. 2003 Mar;39(4):438-46. doi: 10.1016/s0959-8049(02)00732-3. Eur J Cancer. 2003. PMID: 12751373
Influence of neoadjuvant anastrozole (Arimidex) on intratumoral estrogen levels and proliferation markers in patients with locally advanced breast cancer.
Geisler J, Detre S, Berntsen H, Ottestad L, Lindtjørn B, Dowsett M, Einstein Lønning P. Geisler J, et al. Clin Cancer Res. 2001 May;7(5):1230-6. Clin Cancer Res. 2001. PMID: 11350888 Clinical Trial.
Influence of dexaminoglutethimide, an optical isomer of aminoglutethimide, on the disposition of estrone sulfate in postmenopausal breast cancer patients.
Geisler J, Lundgren S, Berntsen H, Greaves JL, Lønning PE. Geisler J, et al. J Clin Endocrinol Metab. 1998 Aug;83(8):2687-93. doi: 10.1210/jcem.83.8.5035. J Clin Endocrinol Metab. 1998. PMID: 9709932 Clinical Trial.

The clearance rate of E1S increased from a mean pretreatment value of 5.9 to 14.0 and 10.0 L/h during treatment with DL-AG and D-AG, respectively (P < 0.05, comparing the two on-treatment situations), whereas the production rate of E1S decreased from a pretreatment valu

The clearance rate of E1S increased from a mean pretreatment value of 5.9 to 14.0 and 10.0 L/h during treatment with DL-AG and D-AG, …
Differential effect of carbamazepine and valproate monotherapy on plasma levels of oestrone sulphate and dehydroepiandrosterone sulphate in male epileptic patients.
Geisler J, Engelsen BA, Berntsen H, Geisler S, Lønning PE. Geisler J, et al. J Endocrinol. 1997 May;153(2):307-12. doi: 10.1677/joe.0.1530307. J Endocrinol. 1997. PMID: 9166121
Influence of treatment with aminoglutethimide on plasma and red-blood-cell glutathione status in breast cancer patients.
Berntsen H, Lønning PE, Ekse D, Netteland B, Johannessen DC, Berge R, Svardal A. Berntsen H, et al. Cancer Chemother Pharmacol. 1998;42(1):46-52. doi: 10.1007/s002800050783. Cancer Chemother Pharmacol. 1998. PMID: 9619757
Effects of defined mixtures of POPs and endocrine disruptors on the steroid metabolome of the human H295R adrenocortical cell line.
Ahmed KEM, Frøysa HG, Karlsen OA, Blaser N, Zimmer KE, Berntsen HF, Verhaegen S, Ropstad E, Kellmann R, Goksøyr A. Ahmed KEM, et al. Among authors: berntsen hf. Chemosphere. 2019 Mar;218:328-339. doi: 10.1016/j.chemosphere.2018.11.057. Epub 2018 Nov 12. Chemosphere. 2019. PMID: 30476764
Maternal exposure to a mixture of persistent organic pollutants (POPs) affects testis histology, epididymal sperm count and induces sperm DNA fragmentation in mice.
Khezri A, Lindeman B, Krogenæs AK, Berntsen HF, Zimmer KE, Ropstad E. Khezri A, et al. Toxicol Appl Pharmacol. 2017 Aug 15;329:301-308. doi: 10.1016/j.taap.2017.06.019. Epub 2017 Jun 20. Toxicol Appl Pharmacol. 2017. PMID: 28645691
Female mice were exposed via feed from weaning, during pregnancy and lactation in 3 exposure groups (control (C), low (L) and high (H)). ...
Female mice were exposed via feed from weaning, during pregnancy and lactation in 3 exposure groups (control (C), low (L) and high (H
A human exposure based mixture of persistent organic pollutants affects the stress response in female mice and their offspring.
Hudecova AM, Hansen KEA, Mandal S, Berntsen HF, Khezri A, Bale TL, Fraser TWK, Zimmer KE, Ropstad E. Hudecova AM, et al. Chemosphere. 2018 Apr;197:585-593. doi: 10.1016/j.chemosphere.2018.01.085. Epub 2018 Jan 18. Chemosphere. 2018. PMID: 29407821
Effects of defined mixtures of persistent organic pollutants (POPs) on multiple cellular responses in the human hepatocarcinoma cell line, HepG2, using high content analysis screening.
Wilson J, Berntsen HF, Zimmer KE, Frizzell C, Verhaegen S, Ropstad E, Connolly L. Wilson J, et al. Toxicol Appl Pharmacol. 2016 Mar 1;294:21-31. doi: 10.1016/j.taap.2016.01.001. Epub 2016 Jan 7. Toxicol Appl Pharmacol. 2016. PMID: 26772051
38 results
Jump to page
Feedback